Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
3 other identifiers
interventional
2,277
24 countries
216
Brief Summary
The purpose of this study is to evaluate the long-term safety and tolerability of Admilparant in participants who completed participation in parent studies IM027-068 (for idiopathic pulmonary fibrosis (IPF)) and IM027-1015 (for progressive pulmonary fibrosis (PPF)).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Dec 2026
Typical duration for phase_3
216 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
December 16, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2029
Study Completion
Last participant's last visit for all outcomes
March 30, 2030
May 11, 2026
May 1, 2026
2.9 years
February 25, 2026
May 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Number of Participants With Treatment Emergent Adverse Events (TEAEs)
Up to Week 100
Number of Participants With Serious Adverse Events (SAEs)
Up to Week 100
Number of Participants With AEs leading to Discontinuation
Up to Week 100
Number of Participants With AEs leading to Deaths
Up to Week 100
Number of Participants With Clinically Significant Laboraty Abnormalities
Up to Week 100
Number of Participants With Clinically Significant Electocardiogram (ECG) Abnormalities
Up to Week 100
Number of Participants With Clinically Significant Vital Sign Abnormalities
Up to Week 100
Study Arms (1)
BMS-986278 Arm
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- \- Participants must have completed participation in either IM027068 or IM0271015 (defined as receiving study intervention (IMP) until completion of EOT visit).
You may not qualify if:
- Clinically significant AE that resulted in discontinuation or interruption of IMP (Investigational Medicinal Product) in IM027068 or IM0271015 without reinitiation of IMP.
- Exhibit symptoms of heart failure at rest.
- History of lung reduction surgery or lung transplant. Note: Being on the transplantation list is allowed.
- Participants with known PAH (Pulmonary Arterial Hypertension) who has been on single drug therapy that now requires multi-drug therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (216)
Local Institution - 0013
Florida, Vicente López, Buenos Aires, 1602, Argentina
Local Institution - 0014
Mar del Plata, Buenos Aires, 7600, Argentina
Local Institution - 0007
Quilmes, Buenos Aires, 1878, Argentina
Local Institution - 0009
San Juan Bautista, Buenos Aires, 1888, Argentina
Local Institution - 0003
Mar del Plata, B, 7600, Argentina
Local Institution - 0001
Córdoba, Córdoba Province, X5003DCE, Argentina
Local Institution - 0005
CABA, Distrito Federal, C1425FVH, Argentina
Local Institution - 0002
Godoy Cruz, Mendoza Province, 5501, Argentina
Local Institution - 0011
Mendoza, M, 5500, Argentina
Local Institution - 0015
Rosario, S, 2000, Argentina
Local Institution - 0012
San Miguel de Tucumán, Tucumán Province, T4000JCU, Argentina
Local Institution - 0010
Buenos Aires, C1056ABI, Argentina
Local Institution - 0004
Buenos Aires, C1426ABP, Argentina
Local Institution - 0016
CABA, 4190, Argentina
Local Institution - 0006
Mendoza, 5500, Argentina
Local Institution - 0008
Santa Fe, 3000, Argentina
Local Institution - 0287
Camperdown, New South Wales, 2050, Australia
Local Institution - 0290
Chermside, Queensland, 4032, Australia
Local Institution - 0291
Greenslopes, Queensland, 4120, Australia
Local Institution - 0293
South Brisbane, Queensland, 4101, Australia
Local Institution - 0289
Adelaide, South Australia, 5000, Australia
Local Institution - 0288
Frankston, Victoria, 3199, Australia
Local Institution - 0285
Murdoch, Western Australia, 6150, Australia
Local Institution - 0292
Nedlands, Western Australia, 6009, Australia
Local Institution - 0286
Melbourne, 3128, Australia
Local Institution - 0284
Wentworthville, NSW2145, Australia
Local Institution - 0249
Yvoir, Namur, 5530, Belgium
Local Institution - 0252
Leuven, Vlaams-Brabant, 3000, Belgium
Local Institution - 0248
Brussels, 1200, Belgium
Local Institution - 0251
Kortrijk, 8500, Belgium
Local Institution - 0250
Liège, 4000, Belgium
Local Institution - 0166
Sherwood Park, Alberta, T8H 0N2, Canada
Local Institution - 0165
Vancouver, British Columbia, V5Z 1M9, Canada
Local Institution - 0168
Vancouver, British Columbia, V6Z 1Y6, Canada
Local Institution - 0167
Burlington, Ontario, L7N 3V2, Canada
Local Institution - 0170
Hamilton, Ontario, L8N 4A6, Canada
Local Institution - 0163
Owen Sound, Ontario, N4K 6M9, Canada
Local Institution - 0169
Toronto, Ontario, M5T 3A9, Canada
Local Institution - 0171
Greenfield Park, Quebec, J4V 2H1, Canada
Local Institution - 0172
Montreal, Quebec, H2X 1R9, Canada
Local Institution - 0164
Trois-Rivières, Quebec, G8T 7A1, Canada
Local Institution - 0173
Trois-Rivières, Quebec, G9S4P3, Canada
Local Institution - 0054
Concepción, Biobio, 4030000, Chile
Local Institution - 0052
Curicó, Maule Region, 3340000, Chile
Local Institution - 0051
Talca, Maule Region, 3466706, Chile
Local Institution - 0053
Santiago, Santiago Metropolitan, 7620157, Chile
Local Institution - 0050
Quillota, Valparaiso, 2260000, Chile
Local Institution - 0057
Viña del Mar, Valparaiso, 2531172, Chile
Local Institution - 0538
Beijing, Beijing Municipality, 100730, China
Local Institution - 0044
Medellín, ANT, 050021, Colombia
Local Institution - 0047
Medellín, ANT, 050034, Colombia
Local Institution - 0043
Bogotá, DC, 110111, Colombia
Local Institution - 0046
Bogotá, DC, 110131, Colombia
Local Institution - 0041
Floridablanca, Santander Department, 681004, Colombia
Local Institution - 0040
Santiago de Cali, VAC, 760046, Colombia
Local Institution - 0039
Bogotá, 0, Colombia
Local Institution - 0048
Bogotá, Colombia
Local Institution - 0042
Manizales, 0, Colombia
Local Institution - 0045
Zipaquirá, 250252, Colombia
Local Institution - 0487
Hellerup, Capital Region, 2900, Denmark
Local Institution - 0488
Aarhus, Region Midt, 8200, Denmark
Local Institution - 0486
Odense C, Region Syddanmark, 5000, Denmark
Local Institution - 0489
Copenhagen, 2100, Denmark
Local Institution - 0491
Turku, Laensi-Suomen Laeaeni, 20521, Finland
Local Institution - 0490
Helsinki, 00290, Finland
Local Institution - 0245
Grenoble, Auvergne-Rhône-Alpes, 38043, France
Local Institution - 0236
Angers, Maine-et-Loire, 49933, France
Local Institution - 0246
Nantes, Pays de la Loire Region, 44093, France
Local Institution - 0243
Marseille, Provence-Alpes-Côte d'Azur Region, 13015, France
Local Institution - 0242
Bobigny, 93009, France
Local Institution - 0238
Brest, 29609, France
Local Institution - 0244
Dijon, 21000, France
Local Institution - 0240
Nice, 06000, France
Local Institution - 0239
Paris, 75018, France
Local Institution - 0241
Pessac, 33604, France
Local Institution - 0247
Saint-Genis-Laval, 69563, France
Local Institution - 0237
Toulouse, 31059, France
Local Institution - 0234
Heraklion, 711 10, Greece
Local Institution - 0229
Ioannina, Ípeiros, 455 00, Greece
Local Institution - 0269
Belagavi, Karnataka, 590010, India
Local Institution - 0263
Nagpur, Maharashtra, 044009, India
Local Institution - 0261
Pune, Maharashtra, 411001, India
Local Institution - 0266
Pune, Maharashtra, 411001, India
Local Institution - 0265
Pune, Maharashtra, 411004, India
Local Institution - 0268
New Delhi, National Capital Territory of Delhi, 110 030, India
Local Institution - 0260
Dehradun, Uttarakhand, 248001, India
Local Institution - 0258
Kolkata, West Bengal, 700014, India
Local Institution - 0270
Kolkata, West Bengal, 700027, India
Local Institution - 0264
Ahemdabad, 380060, India
Local Institution - 0271
Bangalore, 560034, India
Local Institution - 0272
Delhi, 110029, India
Local Institution - 0274
Jaipur, 302039, India
Local Institution - 0259
Lucknow, 226006, India
Local Institution - 0273
Lucknow, 226021, India
Local Institution - 0275
Nagpur, 440010, India
Local Institution - 0495
Tallaght, Dublin, 0, Ireland
Local Institution - 0493
Drogheda, Louth, A92 VW28, Ireland
Local Institution - 0494
Dublin, 0, Ireland
Local Institution - 0492
Dublin, D15 X40D, Ireland
Local Institution - 0279
Petah Tikva, 4941492, Israel
Local Institution - 0211
Florence, Tuscany, 50134, Italy
Local Institution - 0221
Palermo, 90127, Italy
Local Institution - 0516
Nagoya, Aichi-ken, 466-8560, Japan
Local Institution - 0517
Seto-shi, Aichi-ken, 489-8642, Japan
Local Institution - 0512
Kamogawa-Shi, Chiba, 296-0041, Japan
Local Institution - 0536
Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan
Local Institution - 0530
Chikushino-shi, Fukuoka, 818-8502, Japan
Local Institution - 0528
Fukuoka, Fukuoka, 810-8563, Japan
Local Institution - 0531
Iizuka-shi, Fukuoka, 820-8505, Japan
Local Institution - 0532
Kurume-Shi, Fukuoka, 830-0011, Japan
Local Institution - 0537
Kōriyama, Fukushima, 963-0197, Japan
Local Institution - 0526
Hiroshima, Hiroshima, 734-8530, Japan
Local Institution - 0498
Sapporo, Hokai-do, 060-8543, Japan
Local Institution - 0499
Sapporo, Hokkaido, 060-8648, Japan
Local Institution - 0524
Himeji-Shi, Hyōgo, 670-8520, Japan
Local Institution - 0523
Kobe, Hyōgo, 650-0047, Japan
Local Institution - 0513
Naka-gun, Ibaraki, 319-1113, Japan
Local Institution - 0510
Yokohama, Kanagawa, 2360051, Japan
Local Institution - 0518
Matsusaka-shi, Mie-ken, 515-8544, Japan
Local Institution - 0522
Tenri-shi, Nara, 632-8552, Japan
Local Institution - 0535
Ginowan-Shi, Okinawa, 901-2214, Japan
Local Institution - 0520
Sakai, Osaka, 590-0197, Japan
Local Institution - 0521
Sakai, Osaka, 591-8555, Japan
Local Institution - 0519
Takatsuki, Osaka, 569-8686, Japan
Local Institution - 0525
Izumo-shi, Shimane, 693-8501, Japan
Local Institution - 0515
Hamamatsu, Shizuoka, 431-3192, Japan
Local Institution - 0514
Shimotsuke, Tochigi, 329-0498, Japan
Local Institution - 0502
Bunkyo-ku, Tokyo, 113-8431, Japan
Local Institution - 0503
Bunkyo-ku, Tokyo, 113-8519, Japan
Local Institution - 0504
Bunkyo-Ku, Tokyo, 113-8603, Japan
Local Institution - 0501
Minato-ku, Tokyo, 105-8471, Japan
Local Institution - 0509
Mitaka-shi, Tokyo, 181-8611, Japan
Local Institution - 0505
Ōta-ku, Tokyo, 143-8541, Japan
Local Institution - 0508
Shinjyu-Ku, Tokyo, 162-8655, Japan
Local Institution - 0527
Ube, Yamaguchi, 755-0241, Japan
Local Institution - 0511
Chiba, 260-8677, Japan
Local Institution - 0529
Fukuoka, 812-8582, Japan
Local Institution - 0534
Kumamoto, 861-4193, Japan
Local Institution - 0533
Nagasaki, 852-8501, Japan
Local Institution - 0507
Shinjyuku-ku, 160-0023, Japan
Local Institution - 0500
Tokyo, 105-8470, Japan
Local Institution - 0506
Tokyo, 153-8515, Japan
Local Institution - 0019
Aguascalientes, Aguascalientes, 20116, Mexico
Local Institution - 0037
Chihuahua City, Chihuahua, 31203, Mexico
Local Institution - 0036
México, DIF, 14050, Mexico
Local Institution - 0023
Metepec, Edo de Mexico, 52170, Mexico
Local Institution - 0022
Guadalajara, Jalisco, 44160, Mexico
Local Institution - 0021
Guadalajara, Jalisco, 44340, Mexico
Local Institution - 0024
Morelia, Michoacán, 58260, Mexico
Local Institution - 0038
Monterrey, Nuevo León, 64460, Mexico
Local Institution - 0017
Oaxaca City, Oaxaca, 68000, Mexico
Local Institution - 0020
Oaxaca City, Oaxaca, 68020, Mexico
Local Institution - 0035
Col Garcia Binersa, Yucatán, 97070, Mexico
Local Institution - 0034
Mérida, Yucatán, 97125, Mexico
Local Institution - 0018
Guadalajara, 44130, Mexico
Local Institution - 0256
Rotterdam, South Holland, 3061BC, Netherlands
Local Institution - 0253
Amsterdam, 1081 BT, Netherlands
Local Institution - 0257
Heerlen, 6419 PC, Netherlands
Local Institution - 0254
Leiden, 2300 RC, Netherlands
Local Institution - 0255
Nieuwegein, 3425 CM, Netherlands
Local Institution - 0063
Lima, LIM, 15033, Peru
Local Institution - 0059
San Miguel, LIM, 15088, Peru
Local Institution - 0058
Lima, 15023, Peru
Local Institution - 0061
Lima, 15073, Peru
Local Institution - 0064
Lima, Lima 27, Peru
Local Institution - 0060
Lima, LIMA 31, Peru
Local Institution - 0065
Lima, Lima 41, Peru
Local Institution - 0062
Piura, 20001, Peru
Local Institution - 0081
Vila Nova de Gaia, Porto District, 4434-502, Portugal
Local Institution - 0077
Lisbon, 1769-001, Portugal
Local Institution - 0078
Loures, 2674-514, Portugal
Local Institution - 0079
Porto, 4099-001, Portugal
Local Institution - 0082
Porto, 4200-319, Portugal
Local Institution - 0203
Ulsan, Dong-gu, 682-714, South Korea
Local Institution - 0206
Goyang-si, Gyeonggi-do, 10475, South Korea
Local Institution - 0197
Busan, Pusan-Kwangyǒkshi, 0, South Korea
Local Institution - 0199
Seoul, Seoul Teugbyeolsi, 03080, South Korea
Local Institution - 0200
Seoul, Seoul-teukbyeolsi, 05505, South Korea
Local Institution - 0208
Bucheon-si, 14584, South Korea
Local Institution - 0207
Bucheon-si, 420-717, South Korea
Local Institution - 0198
Busan, 612-030, South Korea
Local Institution - 0196
Goyang, 411-706, South Korea
Local Institution - 0204
Iksan, 570-711, South Korea
Local Institution - 0205
Incheon, 405-760, South Korea
Local Institution - 0209
Kyunggi-do, 463-707, South Korea
Local Institution - 0202
Seoul, 120-752, South Korea
Local Institution - 0195
Seoul, 140-887, South Korea
Local Institution - 0201
Suwon, 16499, South Korea
Local Institution - 0083
Santander, Cantabria, 39008, Spain
Local Institution - 0085
Santiago de Compostela, C, 15706, Spain
Local Institution - 0069
Barcelona, 08036, Spain
Local Institution - 0074
Barcelona, 08907, Spain
Local Institution - 0075
Barcelona, 8035, Spain
Local Institution - 0071
Coslada, 28822, Spain
Local Institution - 0073
Girona, 17001, Spain
Local Institution - 0068
Madrid, 28006, Spain
Local Institution - 0067
Madrid, 28040, Spain
Local Institution - 0084
Madrid, 28040, Spain
Local Institution - 0072
Madrid, 28046, Spain
Local Institution - 0076
Málaga, 29010, Spain
Local Institution - 0070
Oviedo, 33006, Spain
Local Institution - 0323
Kaohsiung City, 807, Taiwan
Local Institution - 0321
Kaohsiung City, 83301, Taiwan
Local Institution - 0322
Taichung, 404332, Taiwan
Local Institution - 0325
Taichung, 407, Taiwan
Local Institution - 0324
Taipei, 100, Taiwan
Local Institution - 0326
Taipei, 112, Taiwan
Local Institution - 0316
Birmingham, BIR, B9 5SS, United Kingdom
Local Institution - 0317
Cambridge, Cambridgeshire, CB2 0AY, United Kingdom
Local Institution - 0312
Edinburgh, EDH, EH16 4SA, United Kingdom
Local Institution - 0315
London, Greater London, SW3 6NP, United Kingdom
Local Institution - 0314
Peterborough, PTE, PE3 9GZ, United Kingdom
Local Institution - 0497
Cottingham, Yorkshire and the Humber, HU16 5JQ, United Kingdom
Local Institution - 0496
Leeds, Yorkshire, LS9 7TF, United Kingdom
Local Institution - 0319
Birmingham, B15 2WB, United Kingdom
Local Institution - 0318
Oxford, OX3 7LE, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Central Study Contacts
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
First line of the email MUST contain NCT # and Site #.
CONTACT
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2026
First Posted
March 2, 2026
Study Start (Estimated)
December 16, 2026
Primary Completion (Estimated)
November 22, 2029
Study Completion (Estimated)
March 30, 2030
Last Updated
May 11, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- See Plan Description
- Access Criteria
- See Plan Description
BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html